Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 3:51 a.m.

    📋 REPLIMUNE GROUP, INC. (REPL) - Clinical Trial Update

    Filing Date: 2022-06-03

    Accepted: 2022-06-03 08:10:25

    Event Type: Clinical Trial Update

    Event Details:

    Replimune Group Inc (REPL) Announces Clinical Trial Update Replimune Group Inc (REPL) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: announced, team
    • Diseases/Conditions: a variety of cancer types, Woburn
    • Collaboration: Board of Directors

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Replimune Group Inc
    • CIK: 0001737953
    • Ticker Symbol: REPL
    • Period End Date: 2022-05-31
    • Document Type: 8-K

Search

News categories